Literature DB >> 26910103

Peripheral monocytes are functionally altered and invade the CNS in ALS patients.

Lisa Zondler1, Kathrin Müller1, Samira Khalaji2, Corinna Bliederhäuser1, Wolfgang P Ruf1, Veselin Grozdanov1, Meinolf Thiemann3, Katrin Fundel-Clemes4, Axel Freischmidt1, Karlheinz Holzmann5, Benjamin Strobel4, Patrick Weydt1, Anke Witting1, Dietmar R Thal1, Anika M Helferich1, Bastian Hengerer4, Kay-Eberhard Gottschalk2, Oliver Hill3, Michael Kluge3, Albert C Ludolph1, Karin M Danzer1, Jochen H Weishaupt6.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating progressive neurodegenerative disease affecting primarily the upper and lower motor neurons. A common feature of all ALS cases is a well-characterized neuroinflammatory reaction within the central nervous system (CNS). However, much less is known about the role of the peripheral immune system and its interplay with CNS resident immune cells in motor neuron degeneration. Here, we characterized peripheral monocytes in both temporal and spatial dimensions of ALS pathogenesis. We found the circulating monocytes to be deregulated in ALS regarding subtype constitution, function and gene expression. Moreover, we show that CNS infiltration of peripheral monocytes correlates with improved motor neuron survival in a genetic ALS mouse model. Furthermore, application of human immunoglobulins or fusion proteins containing only the human Fc, but not the Fab antibody fragment, increased CNS invasion of peripheral monocytes and delayed the disease onset. Our results underline the importance of peripheral monocytes in ALS pathogenesis and are in agreement with a protective role of monocytes in the early phase of the disease. The possibility to boost this beneficial function of peripheral monocytes by application of human immunoglobulins should be evaluated in clinical trials.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Fc receptor; Immunoglobulin; Innate immunity; Microglia; Monocyte

Mesh:

Year:  2016        PMID: 26910103     DOI: 10.1007/s00401-016-1548-y

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  49 in total

Review 1.  Neuroimmune interaction in seizures and epilepsy: focusing on monocyte infiltration.

Authors:  Dale B Bosco; Dai-Shi Tian; Long-Jun Wu
Journal:  FEBS J       Date:  2020-06-15       Impact factor: 5.542

Review 2.  Differential contribution of microglia and monocytes in neurodegenerative diseases.

Authors:  Caroline Baufeld; Elaine O'Loughlin; Narghes Calcagno; Charlotte Madore; Oleg Butovsky
Journal:  J Neural Transm (Vienna)       Date:  2017-10-23       Impact factor: 3.575

Review 3.  Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.

Authors:  Lucas T Vu; Robert Bowser
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

Review 4.  Dopaminergic Regulation of Innate Immunity: a Review.

Authors:  Monica Pinoli; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-03       Impact factor: 4.147

5.  Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes.

Authors:  Weihua Zhao; David R Beers; Kristopher G Hooten; Douglas H Sieglaff; Aijun Zhang; Shanker Kalyana-Sundaram; Christopher M Traini; Wendy S Halsey; Ashley M Hughes; Ganesh M Sathe; George P Livi; Guo-Huang Fan; Stanley H Appel
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

6.  Impaired activation of ALS monocytes by exosomes.

Authors:  Lisa Zondler; Marisa S Feiler; Axel Freischmidt; Wolfgang P Ruf; Albert C Ludolph; Karin M Danzer; Jochen H Weishaupt
Journal:  Immunol Cell Biol       Date:  2016-09-12       Impact factor: 5.126

7.  Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression.

Authors:  Benjamin J Murdock; Tingting Zhou; Samy R Kashlan; Roderick J Little; Stephen A Goutman; Eva L Feldman
Journal:  JAMA Neurol       Date:  2017-12-01       Impact factor: 18.302

Review 8.  Microglial signatures and their role in health and disease.

Authors:  Oleg Butovsky; Howard L Weiner
Journal:  Nat Rev Neurosci       Date:  2018-10       Impact factor: 34.870

Review 9.  Non-neuronal cells in amyotrophic lateral sclerosis - from pathogenesis to biomarkers.

Authors:  Björn F Vahsen; Elizabeth Gray; Alexander G Thompson; Olaf Ansorge; Daniel C Anthony; Sally A Cowley; Kevin Talbot; Martin R Turner
Journal:  Nat Rev Neurol       Date:  2021-04-29       Impact factor: 42.937

10.  Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival.

Authors:  Aude Chiot; Sakina Zaïdi; Charlène Iltis; Matthieu Ribon; Félix Berriat; Lorenzo Schiaffino; Ariane Jolly; Pierre de la Grange; Michel Mallat; Delphine Bohl; Stéphanie Millecamps; Danielle Seilhean; Christian S Lobsiger; Séverine Boillée
Journal:  Nat Neurosci       Date:  2020-10-19       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.